Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors - Summary - MDSpire

Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors

  • By

  • James L. Rogers

  • Thomas Wall

  • Alvina A. Acquaye-Mallory

  • Lisa Boris

  • Yeonju Kim

  • Kenneth Aldape

  • Martha M. Quezado

  • John A. Butman

  • James G. Smirniotopoulos

  • Huma Chaudhry

  • Christina I. Tsien

  • Prashant Chittiboina

  • Kareem Zaghloul

  • Orwa Aboud

  • Nicholas G. Avgeropoulos

  • Eric C. Burton

  • David M. Cachia

  • Karan S. Dixit

  • Jan Drappatz

  • Erin M. Dunbar

  • Peter Forsyth

  • Edina Komlodi-Pasztor

  • Jacob Mandel

  • Byram H. Ozer

  • Eudocia Q. Lee

  • Surabhi Ranjan

  • Rimas V. Lukas

  • Margarita Raygada

  • Michael E. Salacz

  • Matthew A. Smith-Cohn

  • James Snyder

  • Ariane Soldatos

  • Brett J. Theeler

  • Brigitte C. Widemann

  • Kevin A. Camphausen

  • John D. Heiss

  • Terri S. Armstrong

  • Mark R. Gilbert

  • Marta Penas-Prado

  • March 1, 2024

  • 0 min

Share

Objective:

To evaluate the utility of virtual multi-institutional tumor boards (MTBs) in diagnosing and managing rare CNS tumors, highlighting their significance in improving access to expert care.

Key Findings:
  • Virtual MTBs facilitate collaboration across institutions, enhancing access to expert care for rare CNS tumors, as evidenced by case studies.
  • The format allows for comprehensive case discussions, improving diagnostic accuracy and management strategies, supported by participant feedback.
  • Specialized care through virtual MTBs can reduce misdiagnosis and treatment complications, as shown in preliminary outcome assessments.
Interpretation:

Virtual multi-institutional tumor boards represent a promising strategy to optimize care for patients with rare CNS tumors, overcoming geographic barriers and enhancing multidisciplinary collaboration, with potential implications for future research.

Limitations:
  • The study does not quantify the impact of virtual MTBs on patient outcomes, which limits the ability to draw definitive conclusions.
  • Potential technical issues with virtual meetings may affect participation and discussion quality, warranting further investigation.
Conclusion:

Virtual MTBs can significantly improve the management of rare CNS tumors by facilitating expert collaboration and personalized care strategies, ultimately aiming to enhance patient outcomes.

Original Source(s)

Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors

  • by James L. Rogers, Thomas Wall, Alvina A. Acquaye-Mallory, Lisa Boris, Yeonju Kim, Kenneth Aldape, Martha M. Quezado, John A. Butman, James G. Smirniotopoulos, Huma Chaudhry, Christina I. Tsien, Prashant Chittiboina, Kareem Zaghloul, Orwa Aboud, Nicholas G. Avgeropoulos, Eric C. Burton, David M. Cachia, Karan S. Dixit, Jan Drappatz, Erin M. Dunbar, Peter Forsyth, Edina Komlodi-Pasztor, Jacob Mandel, Byram H. Ozer, Eudocia Q. Lee, Surabhi Ranjan, Rimas V. Lukas, Margarita Raygada, Michael E. Salacz, Matthew A. Smith-Cohn, James Snyder, Ariane Soldatos, Brett J. Theeler, Brigitte C. Widemann, Kevin A. Camphausen, John D. Heiss, Terri S. Armstrong, Mark R. Gilbert, Marta Penas-Prado

  • March 1, 2024

Related Content

A pharmacodynamic study of rapid lactate metabolic modulation by intravenous L-arginine in brain metastases

Peripheral blood monocytes could be associated with brain metastasis and affect patient prognosis in breast cancer: a retrospective study

Case Report: Acute myeloid leukemia with mixed immunophenotypic features and TCF3::ZNF384 fusion in a pediatric patient with CNS involvement: a diagnostic and therapeutic challenge